Expectation training to help people with rheumatoid arthritis reduce their biologic medicine
Tests expectation training to help adults with rheumatoid arthritis lower their biologic medicine.
Key facts
- Who runs it
- Universiteit Leiden
- Where
- 's-Gravenhage, Enschede, Hoorn Nh, Leeuwarden, Leiden, Rotterdam, and Venlo, NetherlandsSee the 7 sites
- Trial code
- Registry title
- Tapering optimisation with placebo-based mechanisms in rheumatoid arthritis: the TOP-RA trial
- Status
- Not yet recruiting
- Phase
- Phase 4
- People taking part
- 231 people, planned
- Started
- 1 Oct 2026
- Expected to end
- 1 Oct 2030
- Type of study
- Interventional
- Record updated
- 5 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with rheumatoid arthritis who use an injected biologic DMARD and are willing to start lowering the dose. It tests whether expectation training helps with this tapering.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Rheumatoid arthritis diagnosed by a rheumatologist. The treating rheumatologist must consider the person ready to start tapering the biologic DMARD.
- Earlier treatment
- Must be using a biologic DMARD by injection pen, given every 7, 10, 14 or 21 days depending on the drug (abatacept, adalimumab, certolizumab, etanercept, infliximab, tocilizumab or sarilumab). It must be at full dose or after one DRESS step.
Main reasons for not taking part
- Cannot smell or has a severely reduced sense of smell
- Allergy or sensitivity to essential oils when inhaled
- Visual or hearing problems that prevent taking part in the trainings
- Wish to become pregnant in the upcoming year
- Currently in, or planning to join, another rheumatoid arthritis medication trial
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Adult (minimum age of 18 years)
- Being able to give informed consent
- Fluent in Dutch (understanding, speaking, and reading)
- Diagnosed with rheumatoid arthritis by a rheumatologist
- Using a biologic DMARDs via an injection pen which is administered weekly or biweekly on a full dose either on that full dose or after one DRESS step such as: . abatacept, administered every 7 or 10 days; . adalimumab, administered every 14 or 21 days; . certolizumab, administered every 14 or 21 days; . etanercept, administered every 7 or 10 days; . Infliximab, administered every 14 or 21 days; . tocilizumab, administered 7 or 10 days; . or sarilumab, administered every 14 or 21 days
- Treating rheumatologist considers the patient eligible to start bDMARD tapering
- Patient is willing to start bDMARD tapering
- Having access to a device with internet (such as a computer, smartphone, or tablet)
Who cannot take part
- Currently participating or planning to participate in another RA medication trial
- Allergy or sensitivity to essential oils when inhaled
- Inability to perceive odours or has a severely reduced olfactory function
- An inability to open the smell stick, which is comparable to opening a small bottle or a marker, leading to exclusion only when no support person is available to provide assistance once a week
- Any visual or auditory impairments that prevent participation in the trainings
- Insufficient cognitive function or inadequate digital skills that prevent participation in training tasks, leading to exclusion only when no support person is available to provide assistance
- Wish to become pregnant in the upcoming year
Where in Netherlands
- Haga Hospital's-Gravenhage, NetherlandsNot yet recruiting
- Medisch Spectrum TwenteEnschede, NetherlandsNot yet recruiting
- Dijklander ZiekenhuisHoorn Nh, NetherlandsNot yet recruiting
- Frisius MCLeeuwarden, NetherlandsNot yet recruiting
- Universiteit LeidenLeiden, NetherlandsNot yet recruiting
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)Rotterdam, NetherlandsNot yet recruiting
- Stichting Viecuri Medisch Centrum voor Noord-LimburgVenlo, NetherlandsNot yet recruiting
About the trial
What the trial wants to find out
To evaluate whether an expectation training, alone or combined with the conditioning regimen, can improve bDMARD tapering compared with regular care.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Official title
- Tapering optimisation with placebo-based mechanisms in rheumatoid arthritis: the TOP-RA trial
- Plain-language title
- Expectation training to help people with rheumatoid arthritis reduce their biologic medicineGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 5 October 2026